Search Tag: biotechnology
2024 25 Apr
Moderna and OpenAI have announced an ongoing collaboration aimed at exploring the potential of artificial intelligence (AI) in revolutionising both business and healthcare. Moderna, a company with a strong digital foundation and a history of utilising machine learning, is looking to integrate generative AI into its operations. This partnership...Read more
2022 09 Sep
Dr Jacques Mallet, former SVP of Portfolio Analytics/Corporate Strategy at Sanofi, joins NEUWAY’s Advisory Board as independent member adding in depth expertise in pharma corporate development, financing and clinical affairs NEUWAY Pharma GmbH, a preclinical-stage biotechnology company specializing in the delivery of innovative biotherapeutic...Read more
2022 21 Jul
Company Continues Commercial Preparations in Advance of Phase III Clinical Trial Readouts for REL-1017 in Major Depressive Disorder Expected in 2022 Relmada Therapeutics, Inc., a late-stage biotechnology company addressing diseases of the central nervous system (CNS) announced the appointment of John Hixon to a newly created position as Head...Read more
2022 11 Apr
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines has announced that Jorge Gomez will join Moderna as Chief Financial Officer, effective Monday, May 9, 2022. He will serve on Moderna's Executive Committee and report to Chief Executive Officer, Stéphane Bancel. "I am pleased to welcome Jorge to Moderna...Read more
2022 25 Jan
Industry veteran brings deep experience in neuroscience and design of brain penetrant molecules, including at Janssen (Johnson & Johnson), to neuro drug discovery efforts Herophilus, a leading biotechnology company developing neurotherapeutics to cure complex brain diseases, has announced the appointment of Brad Savall, Ph.D. as the company’s...Read more